已收盤 02-06 16:00:00 美东时间
-0.060
-0.06%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
Wells Fargo analyst Elyse Greenspan maintains Axis Capital Holdings (NYSE:AXS) with a Overweight and lowers the price target from $124 to $121.
01-30 23:13
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
华盛资讯1月29日讯,埃克斯资本公布2025财年Q4业绩,公司Q4营收17.29亿美元,同比增长18.3%,归母净利润2.82亿美元,扭亏为盈。
01-29 16:07
Axis Capital Holdings (NYSE:AXS) reported quarterly earnings of $3.25 per share which beat the analyst consensus estimate of $3.11 by 4.6 percent. This is a 9.43 percent increase over earnings of $2.97 per share from the
01-29 05:16
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
Wells Fargo analyst Elyse Greenspan maintains Axis Capital Holdings (NYSE:AXS) with a Overweight and raises the price target from $118 to $124.
01-13 22:21
今日重点评级关注:HC Wainwright & Co.:维持MetaVia Inc."买入"评级,目标价从12美元升至40美元;Canaccord Genuity:维持GH Research"买入"评级,目标价从35美元升至39美元
01-07 17:25
AXIS Capital's shares had a "remarkable two years," Joshua Shanker said in the downgrade note. The next two years will be different, he says.
01-07 03:22
B of A Securities analyst Joshua Shanker downgrades Axis Capital Holdings (NYSE:AXS) from Buy to Neutral and lowers the price target from $116 to $115.
01-06 21:22